BNTC (Benitec Biopharma) Accounts Payable: $0.64 Mil (As of Mar. 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $13.21
View Full Analysis

What is Benitec Biopharma Accounts Payable?

Benitec Biopharma BNTC +4.34% 34 Accounts Payable is $0.64 Mil as of Mar. 2026. GuruFocus rates BNTC with a GF Score™ of 34/100.

Benitec Biopharma's Accounts Payable for the quarter that ended in Mar. 2026 was $0.64 Mil.

Benitec Biopharma's quarterly Accounts Payable increased from Sep. 2025 ($0.27 Mil) to Dec. 2025 ($1.02 Mil) but then declined from Dec. 2025 ($1.02 Mil) to Mar. 2026 ($0.64 Mil).

Benitec Biopharma's annual Accounts Payable increased from Jun. 2023 ($1.14 Mil) to Jun. 2024 ($1.35 Mil) but then declined from Jun. 2024 ($1.35 Mil) to Jun. 2025 ($0.20 Mil).

Benitec Biopharma Accounts Payable Related Terms

Benitec Biopharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Accounts Payable Chart

Benitec Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.42 1.14 1.35 0.20

Benitec Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.20 0.27 1.02 0.64
BNTC
34GF Score
Benitec Biopharma Inc BNTC
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.64 Mil mean?
Benitec Biopharma (BNTC) has a Accounts Payable of $0.64 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Benitec Biopharma and its competitors.
Is Benitec Biopharma's Accounts Payable too high?
Benitec Biopharma's current Accounts Payable is $0.64 Mil. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's Accounts Payable compare to IPSC and FBRX?
Benitec Biopharma's Accounts Payable of $0.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Benitec Biopharma and its competitors. Benitec Biopharma's current Accounts Payable is $0.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current Accounts Payable of $0.64 Mil. The current Accounts Payable is $0.64 Mil. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current Accounts Payable is $0.64 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.21
Price